Oct 20, 2026 09:32AM
Oct 20, 2026 09:31AM
Sep 11, 2026 07:30AM
Sep 11, 2026 07:30AM
Aug 12, 2026 06:00AM
Jul 11, 2024 11:46AM
Oct 17, 2023 08:00AM Cognito Therapeutics Appoints Greg Weaver as Chief Financial Officer
Sep 19, 2023 08:00AM
Sep 19, 2023 08:00AM
Sep 18, 2023 07:01AM
Sep 18, 2023 07:00AM
Sep 7, 2023 09:01AM
Sep 7, 2023 09:00AM
Aug 14, 2023 08:30AM Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
Jun 6, 2023 08:30AM
Jun 1, 2023 09:10AM
May 24, 2023 08:03AM
May 24, 2023 08:00AM
May 15, 2023 04:30PM
May 2, 2023 08:04AM
May 2, 2023 08:00AM Eloxx Pharmaceuticals Announces FDA Clearance to Begin Single Ascending Dose Study of ZKN-013
May 2, 2023 08:00AM
Apr 3, 2023 08:00AM
Apr 3, 2023 08:00AM
Mar 28, 2023 04:45PM
Mar 28, 2023 04:45PM
Mar 28, 2023 04:45PM
Feb 27, 2023 04:05PM Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ELX-02 for the Treatment of Alport Syndrome with First Patient Dosed
Feb 27, 2023 04:05PM
Jan 25, 2023 08:00AM
Jan 25, 2023 08:00AM
Dec 1, 2022 08:45AM
Dec 1, 2022 08:45AM
Dec 1, 2022 08:45AM
Nov 10, 2022 05:15PM Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
Nov 10, 2022 05:15PM
Nov 1, 2022 04:30PM
Nov 1, 2022 04:30PM
Sep 14, 2022 04:07PM
Sep 14, 2022 04:05PM
Sep 14, 2022 04:05PM
Sep 14, 2022 04:05PM Eloxx Pharmaceuticals Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
Aug 15, 2022 08:00AM
Aug 15, 2022 08:00AM
Jul 5, 2022 08:00AM
Jul 5, 2022 08:00AM
May 10, 2022 08:00AM
May 10, 2022 08:00AM
Mar 31, 2022 07:00AM Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update
Mar 31, 2022 07:00AM

335,569 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All